GB932257A - Improvements in and relating to derivatives of estradiol - Google Patents
Improvements in and relating to derivatives of estradiolInfo
- Publication number
- GB932257A GB932257A GB24463/60A GB2446360A GB932257A GB 932257 A GB932257 A GB 932257A GB 24463/60 A GB24463/60 A GB 24463/60A GB 2446360 A GB2446360 A GB 2446360A GB 932257 A GB932257 A GB 932257A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydroxy
- hemi
- acetal
- estradiol
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000002159 estradiols Chemical class 0.000 title abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 150000002373 hemiacetals Chemical class 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- -1 steroid hemiacetals Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001299 aldehydes Chemical class 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 150000003515 testosterones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- E—FIXED CONSTRUCTIONS
- E21—EARTH OR ROCK DRILLING; MINING
- E21D—SHAFTS; TUNNELS; GALLERIES; LARGE UNDERGROUND CHAMBERS
- E21D15/00—Props; Chocks, e.g. made of flexible containers filled with backfilling material
- E21D15/14—Telescopic props
- E21D15/44—Hydraulic, pneumatic, or hydraulic-pneumatic props
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mining & Mineral Resources (AREA)
- Structural Engineering (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Geochemistry & Mineralogy (AREA)
- Geology (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises steroid hemiacetals of the general formula:- <FORM:0932257/IV(a)/1> as the individual isomers and mixtures thereof, (in which formula R1 is an alkyl group containing from one to four carbon atoms and being substituted by at least one halogen atom, R2 is hydroxy or acyloxy group, and R4 is a hydroxy or acyloxy group, the isomerism being due to the carbon atom bearing the asterisk) and a process for their preparation by reacting the corresponding 17b -hydroxy compound with an aldehyde R1CHO, after which the hemi-acetal formed is recovered and purified, or if the corresponding esters are desired the hemi-acetal is acylated either before or after the separation and purification steps. Detailed examples illustrate the preparation of estradiol-17-chloral hemi-acetal and certain of its acylates, including the diacetate, diformate, dibenzoate and difuroate and 3-monoacylates, and also estradiol-17-butylchloral hemi-acetal and its diacetate.ALSO:Pharmaceutical preparations comprise estrogenically active estradiol compounds of the general formula <FORM:0932257/VI/1> in which R1 is an alkyl group having 1 to 4 carbon atoms and being substituted by at least one halogen atom, R2 is an hydroxy group or an acyloxy group and R4 is an hydroxy group or an acyloxy group. The compounds can be given orally or by injection, either in the form of an aqueous crystal suspension (particularly the hemiacetal esters) or in solution or dispersion in oil, and the formulations may contain other active ingredients, e.g. testosterone derivatives.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB24463/60A GB932257A (en) | 1960-07-13 | 1960-07-13 | Improvements in and relating to derivatives of estradiol |
CH823561A CH401047A (en) | 1960-07-13 | 1961-07-13 | Process for the preparation of new estradiol derivatives |
BE606091A BE606091A (en) | 1960-07-13 | 1961-07-13 | New derivatives of estradiol and method for their production. |
ES0269112A ES269112A1 (en) | 1960-07-13 | 1961-07-13 | Improvements in and relating to derivatives of estradiol |
FR874712A FR1394M (en) | 1960-07-13 | 1961-10-02 | New derivatives of estradiol. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB24463/60A GB932257A (en) | 1960-07-13 | 1960-07-13 | Improvements in and relating to derivatives of estradiol |
Publications (1)
Publication Number | Publication Date |
---|---|
GB932257A true GB932257A (en) | 1963-07-24 |
Family
ID=10212098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB24463/60A Expired GB932257A (en) | 1960-07-13 | 1960-07-13 | Improvements in and relating to derivatives of estradiol |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE606091A (en) |
CH (1) | CH401047A (en) |
ES (1) | ES269112A1 (en) |
FR (1) | FR1394M (en) |
GB (1) | GB932257A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112999330A (en) * | 2021-03-18 | 2021-06-22 | 成都大学 | Preparation method of estradiol benzoate and oxytocin long-acting suspension injection |
-
1960
- 1960-07-13 GB GB24463/60A patent/GB932257A/en not_active Expired
-
1961
- 1961-07-13 ES ES0269112A patent/ES269112A1/en not_active Expired
- 1961-07-13 CH CH823561A patent/CH401047A/en unknown
- 1961-07-13 BE BE606091A patent/BE606091A/en unknown
- 1961-10-02 FR FR874712A patent/FR1394M/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112999330A (en) * | 2021-03-18 | 2021-06-22 | 成都大学 | Preparation method of estradiol benzoate and oxytocin long-acting suspension injection |
Also Published As
Publication number | Publication date |
---|---|
ES269112A1 (en) | 1962-04-16 |
CH401047A (en) | 1965-10-31 |
BE606091A (en) | 1962-01-15 |
FR1394M (en) | 1962-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4299846A (en) | Dihydroxy-acylanthrones having anti-psoriatic activity | |
GB932257A (en) | Improvements in and relating to derivatives of estradiol | |
GB1399162A (en) | 6-keto-delta1,3,5-10-steroids and process for the manufacture of 6-keto-delta1,3,5-10-steroids | |
US3275623A (en) | 3, 17-disubstituted-1, 3, 5(10)-estratriene derivatives | |
US2151047A (en) | Piperidine compound | |
US2579679A (en) | Stable vitamin b12 composition | |
KR880005079A (en) | 3-Aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compound, preparation method thereof, and pharmaceutical composition containing the same | |
KR860009035A (en) | Preparation of 11-beta substituted steroids | |
US2312483A (en) | Compounds having a pregnane or pregnene skeleton | |
US2231125A (en) | Esters of tocopherols | |
Walter | Isolation of a saponin, hederin, and its sapogenin, hederagenin, from bur clover (Medicago hispida) | |
JPS5536403A (en) | Preparation of 1-benzazonine derivative | |
GB931188A (en) | Novel 19-nor-testosterone-17-hemiacetal and-hemiacetal esters | |
US3060202A (en) | 3-oxygenated 20-hydroxy-18, 20-cyclopregnanes | |
US2312482A (en) | Derivatives of the cyclopentanopolyhydrophenanthrene series | |
DE1927802C2 (en) | DHO-Prostadienäure and pharmaceutical preparations containing them | |
US2253669A (en) | Estradiol higher fatty acid ester | |
US3145221A (en) | 17alpha-lower alkyl, 17alpha-lower alkinyl and 17alpha-lower alkenyl derivatives of 19-nor-delta5-androsten-17beta-ol-3-one | |
US3080391A (en) | 6alpha-chloro-delta1, 4-androstadien-17beta-ol-3-one derivatives | |
FR2424928A1 (en) | 1,6-DIMESYL-3,4-DIMETHYL-D-MANNITOL, PROCESS FOR ITS PREPARATION AND MEDICINES CONTAINING IT | |
US2351844A (en) | Chlorocaffeine nitrate and nitrite and process of making them | |
GB1065982A (en) | Improvements in or relating to polyacetylmethylenediamines | |
Forlano et al. | Preparation and stability of some esters of vitamin A | |
US2835684A (en) | 14alpha hydroxy, 16 halo-pregnene compounds | |
GB652279A (en) | Process for the manufacture of diastereoisomers |